SomnoMed is a global leader in the treatment of obstructive sleep apnea (OSA), listed on the ASX, with more than 1,000,000 patients worldwide benefiting from our clinically proven oral appliance therapy. We operate across 28 countries with a mission to help people sleep better and live longer, healt